BioXcel Therapeutics, Inc. (BTAI)
USD 0.36
(-8.95%)
USD 0.36
(-8.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.38 Million | 375 Thousand | - | - | - | - |
| Cost of Revenue | 1.26 Million | 20 Thousand | 297 Thousand | 188 Thousand | 156 Thousand | 17 Thousand |
| Gross Profit | 120 Thousand | 355 Thousand | -297 Thousand | -188 Thousand | -156 Thousand | -17 Thousand |
| Operating Expenses | 171.9 Million | 160 Million | 106.93 Million | 82.29 Million | 33.6 Million | 19.96 Million |
| Selling, General and Administrative Expenses | 83.41 Million | 68.76 Million | 54.22 Million | 24.3 Million | 7.8 Million | 5.4 Million |
| Research and Development Expenses | 84.32 Million | 91.23 Million | 52.7 Million | 57.99 Million | 25.79 Million | 14.55 Million |
| Other Expenses | 4.16 Million | -427 Thousand | - | - | - | - |
| Cost and Expenses | 173.16 Million | 160.02 Million | 106.93 Million | 82.29 Million | 33.6 Million | 19.96 Million |
| Operating Income | -171.78 Million | -159.64 Million | -106.93 Million | -82.29 Million | -33.6 Million | -19.96 Million |
| Interest Expense | 13.31 Million | 8.21 Million | 40 Thousand | 27 Thousand | - | - |
| Income Tax Expense | - | 6.09 Million | -301 Thousand | -161 Thousand | -633 Thousand | 692 Thousand |
| Earnings before Tax | -179.05 Million | -165.75 Million | -106.93 Million | -82.16 Million | -32.96 Million | -19.27 Million |
| Net Income | -179.05 Million | -171.84 Million | -106.63 Million | -82 Million | -32.33 Million | -19.27 Million |
| Earnings Per Share Basic | -6.15 | -6.13 | -4.04 | -3.78 | -1.99 | -1.32 |
| Earnings Per Share Diluted | -6.15 | -6.13 | -4.04 | -3.78 | -1.99 | -1.32 |
| Weighted Average Shares Outstanding | 29.12 Million | 28.01 Million | 26.37 Million | 21.68 Million | 16.28 Million | 14.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.12 Million | 28.01 Million | 26.37 Million | 21.68 Million | 16.28 Million | 14.57 Million |
| Gross Margin | 0.09 | 0.95 | - | - | - | - |
| EBIT Margin | -119.87 | -420.12 | - | - | - | - |
| Profit Margin | -129.75 | -458.26 | - | - | - | - |
| EBITDA | -165.42 Million | -157.38 Million | -106.99 Million | -81.98 Million | -32.81 Million | -19.25 Million |
| Earnings Before Tax Margin | -124.48 | -425.72 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.1 Million | 582 Thousand | 376 Thousand | 1.38 Million | 341 Thousand | 457 Thousand |
| Cost of Revenue | 139 Thousand | 158 Thousand | 792 Thousand | 1.57 Million | 512 Thousand | 26 Thousand |
| Gross Profit | 965 Thousand | 424 Thousand | -416 Thousand | -198 Thousand | -171 Thousand | 431 Thousand |
| Operating Expenses | 17.02 Million | 24.35 Million | 19.31 Million | 166.13 Million | 43.96 Million | 52.84 Million |
| Selling, General and Administrative Expenses | 9.36 Million | 13.21 Million | 9.58 Million | - | 24.34 Million | 25.87 Million |
| Research and Development Expenses | 7.66 Million | 11.13 Million | 9.73 Million | - | 19.61 Million | 26.97 Million |
| Other Expenses | 12.02 Million | 32 Thousand | 108 Thousand | 394 Thousand | -5000.00 | 537 Thousand |
| Cost and Expenses | 17.16 Million | 24.51 Million | 20.1 Million | 167.71 Million | 44.47 Million | 52.87 Million |
| Operating Income | -16.05 Million | -23.92 Million | -19.72 Million | -166.33 Million | -48.29 Million | -52.41 Million |
| Interest Expense | 3.7 Million | 3.6 Million | 3.43 Million | 13.31 Million | 3.25 Million | 3.25 Million |
| Income Tax Expense | -1.00 | 34.72 Thousand | -5.27 Million | 150.1 Thousand | 3.24 Million | 3.79 Million |
| Earnings before Tax | -8.29 Million | -26.79 Million | -22.25 Million | -179.05 Million | -50.48 Million | -53.51 Million |
| Net Income | -8.29 Million | -26.79 Million | -22.25 Million | -179.05 Million | -50.48 Million | -53.51 Million |
| Earnings Per Share Basic | -0.21 | -0.87 | -0.76 | - | -1.72 | -1.83 |
| Earnings Per Share Diluted | -0.21 | -0.87 | -0.76 | - | -1.72 | -1.83 |
| Weighted Average Shares Outstanding | 40.25 Million | 30.86 Million | 29.44 Million | 29.12 Million | 29.26 Million | 29.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.25 Million | 30.86 Million | 29.44 Million | 29.12 Million | 29.26 Million | 29.18 Million |
| Gross Margin | 0.87 | 0.73 | -1.11 | -0.14 | -0.50 | 0.94 |
| EBIT Margin | -14.48 | -40.98 | -52.26 | - | -126.08 | -109.79 |
| Profit Margin | -7.52 | -46.03 | -59.19 | -129.75 | -148.05 | -117.10 |
| EBITDA | -15.98 Million | -23.85 Million | -19.65 Million | - | -42.99 Million | -50.17 Million |
| Earnings Before Tax Margin | -14.55 | -41.12 | -52.47 | -120.53 | -141.63 | -114.69 |
INDF
477340
SGBLY
4375
ALTG-PA
GNGBY